New embo member's review -: NF-κB and virus infection:: who controls whom

被引:340
作者
Santoro, MG
Rossi, A
Amici, C
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] CNR, INeMM, I-00133 Rome, Italy
关键词
antiviral; cyclopentenone prostanoids; I kappa B kinase; NF-kappa B; viral infection;
D O I
10.1093/emboj/cdg267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among the different definitions of viruses, 'pirates of the cell' is one of the most picturesque, but also one of the most appropriate. Viruses have been known for a long time to utilize a variety of strategies to penetrate cells and, once inside, to take over the host nucleic acid and protein synthesis machinery to build up their own components and produce large amounts of viral progeny. As their genomes carry a minimal amount of information, encoding only a few structural and regulatory proteins, viruses are largely dependent on their hosts for survival; however, despite their apparent simplicity, viruses have evolved different replicative strategies that are regulated in a sophisticated manner. During the last years, the study of the elaborate relationship between viruses and their hosts has led to the understanding of how viral pathogens not only are able to alter the host metabolism via their signaling proteins, but are also able to hijack cellular signaling pathways and transcription factors, and control them to their own advantage. In particular, the nuclear factor-kappaB (NF-kappaB) pathway appears to be an attractive target for common human viral pathogens. This review summarizes what is known about the control of NF-kappaB by viruses, and discusses the possible outcome of NF-kappaB activation during viral infection, which may benefit either the host or the pathogen.
引用
收藏
页码:2552 / 2560
页数:9
相关论文
共 100 条
[81]   An allosteric drug, o,o′-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-κB [J].
Shoji, S ;
Furuishi, K ;
Ogata, A ;
Yamataka, K ;
Tachibana, K ;
Mukai, R ;
Uda, A ;
Harano, K ;
Matsushita, S ;
Misumi, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (03) :745-753
[82]   NF-κB signaling pathways in mammalian and insect innate immunity [J].
Silverman, N ;
Maniatis, T .
GENES & DEVELOPMENT, 2001, 15 (18) :2321-2342
[83]   Hepatitis B virus HBx protein activates transcription factor NF-kappa B by acting on multiple cytoplasmic inhibitors of rel-related proteins [J].
Su, F ;
Schneider, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4558-4566
[84]   Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappa B induction [J].
Sugano, N ;
Chen, WP ;
Roberts, ML ;
Cooper, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (05) :731-737
[85]   RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication [J].
Surabhi, RM ;
Gaynor, RB .
JOURNAL OF VIROLOGY, 2002, 76 (24) :12963-12973
[86]   Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ [J].
Sylla, BS ;
Hung, SC ;
Davidson, DM ;
Hatzivassiliou, E ;
Malinin, NL ;
Wallach, D ;
Gilmore, TD ;
Kieff, E ;
Mosialos, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10106-10111
[87]   Activation of nuclear factor κB in hepatitis C virus infection:: Implications for pathogenesis and hepatocarcinogenesis [J].
Tai, DI ;
Tsai, SL ;
Chen, YM ;
Chuang, YL ;
Peng, CY ;
Sheen, IS ;
Yeh, CT ;
Chang, KSS ;
Huang, SN ;
Kuo, GC ;
Liaw, YF .
HEPATOLOGY, 2000, 31 (03) :656-664
[88]  
Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO
[89]  
2-2
[90]   NF-κB:: a key role in inflammatory diseases [J].
Tak, PP ;
Firestein, GS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :7-11